QIAGEN Gains FDA Clearance for Bloodstream Infection Testing
Germantown, Maryland, and Venlo, Netherlands, August, 10, 2026 QIAGEN has received U.S. Food and Drug Administration (FDA) clearance for...
multiplex PCR
Advertisement
Kirin and Blackmores Launch Cognizin® Cognitive Supplements
TOKYO, July 22, 2026 Kirin Holdings Company, Limited and Blackmores Limited have announced the launch of two new Cognizin®...
Seegene Targets New Global PCR Standard for Reproductive Health
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has announced a comprehensive Syndromic...
Ipsen Completes Memo Therapeutics Acquisition
PARIS, France, July 22, 2026 Ipsen has completed its acquisition of Memo Therapeutics AG, strengthening its Rare Disease pipeline...
Atossa Unveils (Z)-Endoxifen Data for Rare Endocrine Disease
SEATTLE, July 21, 2026 Atossa Therapeutics has presented new preclinical mechanism-driven data supporting the therapeutic potential of (Z)-Endoxifen for...
Advertisements
Seegene USA Wins FDA EUA for Multiplex PCR Assay
SEOUL, South Korea & IRVINE, Calif., July 21, 2026 Seegene USA has received Emergency Use Authorization (EUA) from the...
Advertisement
